Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Dementia with Lewy bodies (DLB) is a common neurodegenerative disorder in which patients exhibit symptoms of dementia and parkinsonism along with fluctuations and hallucinations that can be ...

About 45 million Americans will die of Alzheimer’s disease if effective prevention and treatment are not developed, says Dr. Dale Bredesen, a neuroscience researcher and neurodegenerative ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

It's incredibly difficult to bring a new pharmaceutical drug to market: about 95% of drugs in clinical trials never get approval. For Alzheimer's disease, that percentage changes to 99%.

In our study, there were no differences in cognitive performance between the groups given donepezil or placebo, irrespective of stimulation therapy or standard care. Chapman et al [12] and Matsuda ...

In 2005, the Alzheimer's Disease Cooperative Study Group (ADCSG) published the results of their randomized controlled trial of donepezil in individuals with amnestic mild cognitive impairment (MCI ...